Brokerages Set Integer Holdings Co. (NYSE:ITGR) Target Price at $139.75

Integer Holdings Co. (NYSE:ITGR - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eight research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $139.75.

ITGR has been the topic of a number of research analyst reports. Truist Financial cut their price target on shares of Integer from $150.00 to $147.00 and set a "buy" rating on the stock in a research report on Friday, October 25th. KeyCorp raised their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Citigroup boosted their target price on shares of Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research report on Tuesday, October 1st. Oppenheimer started coverage on shares of Integer in a report on Tuesday, July 16th. They issued an "outperform" rating and a $135.00 price target for the company. Finally, Benchmark upped their price objective on shares of Integer from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday, October 21st.

Hedge Funds Weigh In On Integer

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its position in shares of Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider's stock valued at $446,428,000 after purchasing an additional 23,382 shares during the last quarter. Earnest Partners LLC increased its position in shares of Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock valued at $139,911,000 after purchasing an additional 37,340 shares during the last quarter. Congress Asset Management Co. increased its position in shares of Integer by 3.9% during the 3rd quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider's stock valued at $63,542,000 after purchasing an additional 18,303 shares during the last quarter. Driehaus Capital Management LLC increased its position in shares of Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider's stock valued at $40,880,000 after purchasing an additional 135,750 shares during the last quarter. Finally, Tributary Capital Management LLC increased its position in shares of Integer by 0.3% during the 2nd quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider's stock valued at $33,168,000 after purchasing an additional 772 shares during the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Trading Down 0.8 %

NYSE ITGR traded down $1.05 on Thursday, reaching $134.37. The company had a trading volume of 79,983 shares, compared to its average volume of 311,950. The firm has a market cap of $4.51 billion, a price-to-earnings ratio of 41.80, a P/E/G ratio of 1.82 and a beta of 1.09. Integer has a fifty-two week low of $83.69 and a fifty-two week high of $136.07. The business has a 50 day moving average of $128.18 and a two-hundred day moving average of $121.62. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts' consensus estimates of $1.36 by $0.07. The business had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.27 earnings per share. Analysts forecast that Integer will post 5.33 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.